Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, injection sites do matter for semaglutide — but not in the way most people assume. The three approved sites (abdomen, thigh, and upper arm) all deliver comparable absorption, so the common fear that you're picking a 'best spot' for results is unfounded. What genuinely matters is rotating between sites to protect the skin, keeping your technique consistent, and understanding the small practical differences between each location. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misconception is that the abdomen is somehow superior for semaglutide absorption. It is not. If you have ever wondered whether the injection site matters for semaglutide, clinical guidance and the Wegovy Summary of Product Characteristics confirm that subcutaneous injection into the abdomen, outer thigh, or outer upper arm all produce clinically equivalent systemic exposure, the medicine reaches your bloodstream at comparable levels regardless of which site you choose. You can read the full product-level detail on the semaglutide injection technique page.
What the abdomen does offer is convenience: it is the easiest site to pinch and visualise, particularly when self-injecting without help. That practical advantage explains why it is many people's default, but it carries no pharmacokinetic superiority. If your abdomen is sore, bruised, or needs a week's rest, your thigh or upper arm will do the job just as well. Do not let a preference become a habit that keeps you returning to exactly the same square centimetre of skin week after week.
The overview of semaglutide injection sites covers the anatomy in more detail, including how to identify the right area on the outer thigh versus the front of the thigh, where the tissue is thinner and less suitable.
Although absorption is equivalent across the three sites, the experience of injecting is not identical. A few genuine differences are worth knowing.
Pain and sensitivity. The abdomen tends to have more variable nerve distribution, some people find certain spots sting more, others barely notice the needle. The outer thigh is often reported as less sensitive. Upper arm is practical only if someone else is injecting, or you can brace it against a surface; reaching around to self-administer consistently is difficult.
Bruising and localised reactions. Redness, mild swelling, or a small lump at the injection point are common in the first weeks of treatment, as evidence on semaglutide injection safety confirms. These are almost always self-resolving and not a sign of an adverse reaction. Rotating sites reduces their frequency.
Lipohypertrophy. This is the clinically significant risk of ignoring rotation. Repeatedly injecting the same small area causes the subcutaneous fat to thicken and scar. The result is an area that feels rubbery underhand, and, more importantly, one where absorption becomes unpredictable. People sometimes describe a dose feeling 'weaker' before realising the site has been overused. Mapping a rotation pattern (for example, dividing the abdomen into quadrants and moving clockwise each week) prevents this entirely.
A note on timing: if you store your pen in the fridge door, bring it out about 15 minutes before your injection. Injecting cold semaglutide straight from the fridge increases the chance of localised stinging, room temperature is noticeably more comfortable.
Whichever site you use, a few technique factors are consistent across all three, and getting them right makes a bigger difference to your comfort than site selection alone. The guide to Wegovy injection sites and your Patient Information Leaflet both cover the full detail; this is a summary of the points patients most often miss.
Pinch and angle. For the abdomen and thigh, a gentle pinch of skin helps you target the subcutaneous layer rather than muscle. Injecting into muscle is not dangerous, but it alters the absorption profile and increases pain. The Wegovy pen is designed for subcutaneous use; follow the angle guidance in your PIL.
Needle change. Use a fresh needle for each injection. A used needle is microscopically blunted, which increases drag and discomfort, and can introduce bacteria at the site. If you find you are running short, compatible replacement needles are available separately.
Site cleaning. Wipe the injection area with an alcohol swab and let it dry fully before injecting, injecting through wet skin carries a small infection risk. Dry skin means the alcohol has evaporated. This is a two-second step that people skip once they feel confident; it is still worth doing.
Sharps disposal. Used needles must go into an approved sharps container, not domestic waste. Local authorities and pharmacies offer free disposal; a sharps disposal bin is a simple way to manage this safely at home.
For a broader look at the safety profile of semaglutide and Wegovy, including gastrointestinal side effects and what to watch for, the Wegovy treatment page sets out what is known from trial evidence and MHRA guidance. The NHS also publishes detailed patient-level information in its semaglutide medicines guide, which covers side effects, storage, and when to seek urgent help. For context on how Wegovy compares to other licensed options, the weight-loss treatments overview is a useful starting point.
If you have questions about your specific injection technique, or you are considering starting treatment and want to know which option suits your situation, our prescribers review consultations the same day. You can also find general answers about the treatment process on the frequently asked questions page. For cost context before you begin, the Wegovy price comparison guide explains what private treatment typically includes, and what to watch for when prices look unusually low. When you are ready, start your free consultation and a GPhC-registered prescriber will review your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.